Yunkang Group Limited (HKG:2325)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.8200
-0.0100 (-1.20%)
At close: Mar 27, 2026
Market Cap479.98M -83.6%
Revenue (ttm)706.95M -18.8%
Net Income-789.94M
EPS-1.34
Shares Out585.34M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume171,000
Average Volume893,775
Open0.8400
Previous Close0.8300
Day's Range0.8200 - 0.8400
52-Week Range0.6500 - 4.8400
Beta-0.77
RSI47.45
Earnings DateMar 30, 2026

About Yunkang Group

Yunkang Group Limited operates as a medical operation service provider in the People's Republic of China. The company offers diagnostic testing services for medical institution alliances, including setting up or upgrading diagnostic centers, the establishment of standard operating procedures for diagnostic testing, diagnostic consultation and staff training, procurement of equipment, smart internet of things, and logistics assistance. It also provides diagnostic outsourcing services comprising pathology tests; infectious disease diagnostic test... [Read more]

Sector Healthcare
Founded 2008
Employees 1,146
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2325
Full Company Profile

Financial Performance

In 2024, Yunkang Group's revenue was 711.88 million, a decrease of -20.15% compared to the previous year's 891.50 million. Losses were -791.68 million, 674.2% more than in 2023.

Financial numbers in CNY Financial Statements